ES2112803A1 - New procedure for obtaining an organic product intended for the treatment and curing of melanomas, carcinomas and other cellular or non-cellular diseases. - Google Patents

New procedure for obtaining an organic product intended for the treatment and curing of melanomas, carcinomas and other cellular or non-cellular diseases.

Info

Publication number
ES2112803A1
ES2112803A1 ES09602008A ES9602008A ES2112803A1 ES 2112803 A1 ES2112803 A1 ES 2112803A1 ES 09602008 A ES09602008 A ES 09602008A ES 9602008 A ES9602008 A ES 9602008A ES 2112803 A1 ES2112803 A1 ES 2112803A1
Authority
ES
Spain
Prior art keywords
cellular
venom
curing
obtaining
new procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09602008A
Other languages
Spanish (es)
Other versions
ES2112803B1 (en
Inventor
Gil Salvador Contri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9602008A priority Critical patent/ES2112803B1/en
Publication of ES2112803A1 publication Critical patent/ES2112803A1/en
Application granted granted Critical
Publication of ES2112803B1 publication Critical patent/ES2112803B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

New procedure for obtaining a product intended for curing cellular or non-cellular diseases, in which dilution of 50% of snake venom from male Brazilian rattlesnakes, Crotalus durissus terrificus, and a further 50% of snake venom from female Indian cobras, Naja naja naja, is obtained in a chlorinated sterile physiological serum at ambient temperature and with stabilizing liquids, an appropriate lethal dose being obtained for application to each disease with variable doses, the venoms having been previously extracted from the live snakes, the venom being collected directly from their fangs by means of sterile forceps, and with the introduction of a Petri dish or test tube inside the mouth, exerting pressure on the poison glands for collection of the venom in the dish or test tube.
ES9602008A 1996-09-23 1996-09-23 NEW PROCEDURE FOR THE OBTAINING OF AN ORGANIC PRODUCT INTENDED FOR THE TREATMENT AND HEALING OF MELANOMAS, CARCINOMAS AND OTHER CELLULAR OR NON-CELLULAR DISEASES. Expired - Lifetime ES2112803B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9602008A ES2112803B1 (en) 1996-09-23 1996-09-23 NEW PROCEDURE FOR THE OBTAINING OF AN ORGANIC PRODUCT INTENDED FOR THE TREATMENT AND HEALING OF MELANOMAS, CARCINOMAS AND OTHER CELLULAR OR NON-CELLULAR DISEASES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9602008A ES2112803B1 (en) 1996-09-23 1996-09-23 NEW PROCEDURE FOR THE OBTAINING OF AN ORGANIC PRODUCT INTENDED FOR THE TREATMENT AND HEALING OF MELANOMAS, CARCINOMAS AND OTHER CELLULAR OR NON-CELLULAR DISEASES.

Publications (2)

Publication Number Publication Date
ES2112803A1 true ES2112803A1 (en) 1998-04-01
ES2112803B1 ES2112803B1 (en) 1998-12-01

Family

ID=8296116

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9602008A Expired - Lifetime ES2112803B1 (en) 1996-09-23 1996-09-23 NEW PROCEDURE FOR THE OBTAINING OF AN ORGANIC PRODUCT INTENDED FOR THE TREATMENT AND HEALING OF MELANOMAS, CARCINOMAS AND OTHER CELLULAR OR NON-CELLULAR DISEASES.

Country Status (1)

Country Link
ES (1) ES2112803B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007740A3 (en) * 2000-07-24 2002-06-20 Bayer Ag Snake toxin and use thereof as a pharmaceutical

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE675605C (en) * 1936-09-11 1939-06-02 August Wolff Sudbracker Naehrm Process for the separation and extraction of the valuable components of bee and snake venom
ES8600941A1 (en) * 1984-05-25 1985-11-01 Contri Gil Salvador Prepn. of substances curing cancer, etc.
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE675605C (en) * 1936-09-11 1939-06-02 August Wolff Sudbracker Naehrm Process for the separation and extraction of the valuable components of bee and snake venom
ES8600941A1 (en) * 1984-05-25 1985-11-01 Contri Gil Salvador Prepn. of substances curing cancer, etc.
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
US5232911A (en) * 1990-01-03 1993-08-03 Ventech Research Inc. Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A. CHAIM-MATYAS et al. Cytotoxic activity of various Snake Venoms on melanoma, B16F10 and Chondrosarcoma. Life Sciences, Pergamon Journals, 1987. Vol. 40, n‘ 16; pßginas 1601-1607 *
A. ZAHEER et al. Comparative Study of Three Basic Polypeptides from Snake Venoms in Relation to their effects on the Cell membrane of Normal and Tumor Cells. Cancer Biochem. Biophys., 1980. Vol. 5, pßginas 41-46 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007740A3 (en) * 2000-07-24 2002-06-20 Bayer Ag Snake toxin and use thereof as a pharmaceutical

Also Published As

Publication number Publication date
ES2112803B1 (en) 1998-12-01

Similar Documents

Publication Publication Date Title
Gurung et al. Wound healing properties of Carica papaya latex: in vivo evaluation in mice burn model
ES2112803A1 (en) New procedure for obtaining an organic product intended for the treatment and curing of melanomas, carcinomas and other cellular or non-cellular diseases.
Gabriel et al. In vitro and in vivo neutralizing activity of Uvaria chamae leaves fractions on the venom of Naja nigricollis in albino rat and bovine blood
Sbai et al. Acute carpal tunnel syndrome of the hand following a cat bite
Tytgat et al. Etiopathogenetic studies in a patient with Whipple’s disease
Adam et al. Pyoderma gangrenosum severely affecting both hands
Burgess Myiasis: maggot infestation
Burns et al. Active chronic hepatitis and pyoderma gangrenosum: report of a case
Mathieu et al. Challenges of the induced-membrane technique in the reconstruction of traumatic tibial defect with limited resources: a cohort study
Iyekowa et al. Bioactive chemical constituents screening and inhibitory activities of methanol extract of Oecophylla Longinoda (Tailor Ant) Against Some pathogens
ES8600941A1 (en) Prepn. of substances curing cancer, etc.
Delori et al. Preparation by immunoaffinity chromatography of phospholipase-free cardiotoxins from the venom of the Elapidae snake Naja mossambica mossambica
Awada et al. Clinical, radiological, and laboratory findings in Lebanese spondylarthropathy patients according to HLA-B27 status
Çeçen et al. Interdigital necrobacillosis associated with Trueperella pyogenes in goitered gazelles (Gazella subgutturosa)
Hager et al. Tungiasis in the United States: a travel souvenir
Bouthors Crucial new insights into the understanding and treatment of acute obstetric coagulopathy
Yadav et al. Physiological amputation of limb (limb gangrene) after tourniquet application for 12 days following snake bite
CN108904902A (en) Double syringe autologous plasma collection device and the method for collecting blood plasma
CN101954116A (en) Manufacturing method of xenoskin used for burns and scalds
RU2067856C1 (en) Medicinal napkin
Culligan, GA, Grant, C., Robbs Actinomadura pelletieri mycetoma from the Transvaal-a case report
Schieferstein The immunology of malignant melanoma
Fernández et al. Clinical Application of a Synthetic Hybrid-Scale Fiber Matrix in a Pediatric Trauma Patient
Hajer et al. The first documented case of loxoscelism in Central Europe-Case report
SU1308321A1 (en) Curette

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980401

Kind code of ref document: A1

Effective date: 19980401